Organizational Structure and Shareholders

Board of Directors

Dr. Abdolali Rajaei

CEO and Vice Chairman of the Board

PhD in Pharmacy

Seyed Ahmad Hosseini Dastjerdi

Chairman of the Board

EDBMA in Industrial Management and DBA in Industrial Management

Dr. Mohsen Hamedani

Member of the Board

PhD in Pharmacy

Zabihollah Sadeghi

Member of the Board

Accounting

CEO

Scientific Records

SUPAC
Standard gowning at different cleanliness levels of pharmaceutical plants
Organizational self-assessment based on the National Quality Award model
Infographics
Risk Management
Introduction to RADAR logic (2010)
Knowledge Management
Novel drug delivery methods
Manufacture of Augmentin tablets
Structured continuing education program for pharmacists
Validation of air handling (HVAC) systems
Basic, Structure & Documentation Of QMS
Conference on production and operations management with a practical approach
Quality Risk Management (QRM)
Proper use of antibiotics in gynecological diseases
Financial fundamentals for non-financial managers
GMP Training Course on Risk Assessment
Introduction to the principles and fundamentals of infographics
Workshop on the 9 principles of GMP (PIC/S)
Internal audit of Integrated Management Systems (IMS)
In-person continuing medical education program
Introduction to the National Quality Award model
Conference on drug management in special circumstances
Implementation of quality and environmental management systems

Skills and Experiences

PhD in Pharmacy from Isfahan University of Medical Sciences
Executive Deputy and Production Manager at Farabi Pharmaceutical Company for 30 years
Member of the Board of Directors at Farabi Pharmaceutical Company and Tofigh Darou
Managing Director at Barij Essence Pharmaceutical Company for 2 years

Shareholders

Farabi Pharmaceutical Company is listed on the Stock Exchange in the pharmaceutical materials and products industry group, chemical and herbal drug production sub-group, under the 12-digit symbol code IRO1DFRB0001. The company’s Persian ticker is “Dfara” (دفارا), traded on the First Market (secondary board), board code 3. The company’s shareholders are as follows: